- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
Patent holdings for IPC class A61P 25/02
Total number of patents in this class: 2100
10-year publication summary
|
66
|
80
|
115
|
148
|
202
|
167
|
205
|
183
|
172
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2943 |
27 |
| Daiichi Sankyo Company, Limited | 1864 |
21 |
| Shionogi & Co., Ltd. | 889 |
20 |
| Osaka University | 3295 |
17 |
| Mitsubishi Tanabe Pharma Corporation | 576 |
15 |
| Novartis AG | 11254 |
14 |
| The Regents of the University of California | 19517 |
14 |
| Kyoto University | 2778 |
14 |
| Bristol-myers Squibb Company | 4863 |
13 |
| Ono Pharmaceutical Co., Ltd. | 435 |
13 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 45 |
13 |
| Toray Industries, Inc. | 6855 |
12 |
| Grünenthal GmbH | 598 |
12 |
| Janssen Pharmaceutica N.V. | 3612 |
11 |
| Banyu Pharmaceutical Co., Ltd. | 84 |
11 |
| Biogen MA Inc. | 914 |
11 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
11 |
| King's College London | 521 |
11 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 149 |
11 |
| Eurofarma Laboratorios S.A. | 35 |
10 |
| Other owners | 1819 |